A. Michael Parfitt

A. Michael Parfitt's AcademicInfluence.com Rankings

A. Michael Parfitt

Biology

#3996

World Rank

#6027

Historical Rank

Anatomy

#18

World Rank

#124

Historical Rank

biology Degrees

Download Badge

Biology

Why Is A. Michael Parfitt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

A. Michael Parfitt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee (1987) (5046)
Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee (2013) (1974)
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. (1998) (1645)
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. (1983) (1545)
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. (1999) (1004)
Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone (1994) (971)
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. (1999) (876)
Bone remodeling. (1988) (673)
Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids* (2007) (592)
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines (1998) (568)
Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system). (1988) (552)
Vitamin D and bone health in the elderly. (1982) (523)
Bone Loss and Bone Turnover in Diabetes (1995) (475)
Osteocyte Apoptosis Is Induced by Weightlessness in Mice and Precedes Osteoclast Recruitment and Bone Loss (2006) (466)
Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. (2005) (450)
Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. (2002) (433)
Calcium nutrition and bone health in the elderly. (1982) (374)
Soft-tissue calcification in uremia. (1969) (372)
Trabecular bone architecture in the pathogenesis and prevention of fracture. (1987) (368)
The coupling of bone formation to bone resorption: a critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis. (1982) (365)
What old means to bone (2010) (355)
Drugs Used to Treat Osteoporosis: The Critical Need for a Uniform Nomenclature Based on Their Action on Bone Remodeling (2004) (350)
Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. (1996) (350)
The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures (1985) (350)
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. (2002) (347)
Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates (1996) (341)
Procollagen type I carboxy‐terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase (1987) (340)
The two faces of growth: Benefits and risks to bone integrity (1994) (305)
Normative data for iliac bone histomorphometry in growing children. (1992) (298)
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. (2000) (291)
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. (1996) (278)
Reversal of Bone Loss in Mice by Nongenotropic Signaling of Sex Steroids (2002) (273)
Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs. (2005) (271)
The mechanism of coupling: a role for the vasculature. (2000) (270)
Structural and cellular changes during bone growth in healthy children. (2000) (267)
Effects of Ethnicity and Age or Menopause on the Remodeling and Turnover of Iliac Bone: Implications for Mechanisms of Bone Loss (1997) (249)
Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. (1988) (245)
Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. (2000) (240)
Misconceptions (2): turnover is always higher in cancellous than in cortical bone. (2002) (236)
Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia (1997) (232)
Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biomechanical consequences (2006) (230)
Relations between histologic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis (1995) (227)
Implications of architecture for the pathogenesis and prevention of vertebral fracture. (1992) (223)
The cellular basis of bone remodeling: The quantum concept reexamined in light of recent advances in the cell biology of bone (2006) (220)
The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation. (1976) (214)
The hyperparathyroidism of chronic renal failure: a disorder of growth. (1997) (210)
Chapter 11 – Osteomalacia and Related Disorders (1998) (197)
Skeletal Heterogeneity and the Purposes of Bone Remodeling: Implications for the Understanding of Osteoporosis (2001) (196)
Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. (1987) (193)
Bone histomorphometry: Proposed system for standardization of nomenclature, symbols, and units (1988) (185)
Perspective: Quantifying Osteoblast and Osteocyte Apoptosis: Challenges and Rewards (2007) (179)
Bone remodeling and bone loss: understanding the pathophysiology of osteoporosis. (1987) (178)
A Structural Approach to Renal Bone Disease (1998) (171)
Vertebral Bone Mass, Size, and Volumetric Density in Women with Spinal Fractures (1999) (165)
Osteomalacia: current concepts. (1978) (164)
Reversal of bone loss in mice by nongenotropic signaling of sex steroids. (2003) (158)
Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. (1988) (156)
The Bone Remodeling Compartment: A Circulatory Function for Bone Lining Cells (2001) (155)
Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. (2000) (154)
Reduced Iliac Cancellous Osteocyte Density in Patients With Osteoporotic Vertebral Fracture (2003) (152)
The morphological association between microcracks and osteocyte lacunae in human cortical bone. (2005) (141)
Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. (2003) (140)
Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone. (2002) (136)
Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. (2003) (134)
Effect of ethnicity and age or menopause on the structure and geometry of iliac bone (1996) (133)
Bone and plasma calcium homeostasis. (1987) (132)
Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. (1985) (131)
Parathyroid Hormone and Periosteal Bone Expansion (2002) (128)
What is bone mineralization? (2003) (128)
Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis (1979) (125)
The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage. (1997) (125)
Irreversible bone loss in osteomalacia. Comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. (1985) (121)
The cellular basis of bone turnover and bone loss: a rebuttal of the osteocytic resorption--bone flow theory. (1977) (117)
Ethnic differences in regional bone density, hip axis length, and lifestyle variables among healthy black and white men (1995) (114)
Bone resorption and formation on the periosteal envelope of the ilium: A histomorphometric study in healthy women (1992) (113)
Structural and geometric changes in iliac bone: Relationship to normal aging and osteoporosis (1991) (109)
The interactions of thiazide diuretics with parathyroid hormone and vitamin D. Studies in patients with hypoparathyroidism. (1972) (109)
Effects of Ethnicity and Age or Menopause on Osteoblast Function, Bone Mineralization, and Osteoid Accumulation in Iliac Bone (1997) (107)
DIETARY RISK FACTORS FOR AGE-RELATED BONE LOSS AND FRACTURES (1983) (105)
Quantification of Vitamin D Receptor mRNA by Competitive Polymerase Chain Reaction in PBMC: Lack of Correspondence with Common Allelic Variants (1997) (101)
Metabolic bone disease after intestinal bypass for treatment of obesity. (1978) (99)
Relationships between osteocyte density and bone formation rate in human cancellous bone. (2002) (97)
Frequency distributions of tetracycline‐based measurements: Implications for the interpretation of bone formation indices in the absence of double‐labeled surfaces (1990) (96)
The long-term skeletal effects of EHDP in dogs. (1981) (94)
A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis (1991) (92)
Mineralized bone loss at different sites in dialysis patients: implications for prevention. (1998) (88)
Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. (1969) (82)
Genetic effects on bone mass and turnover-relevance to black/white differences. (1997) (81)
Equilibrium and disequilibrium hypercalcemia new light on an old concept (1979) (81)
Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women (2003) (80)
Hyperparathyroidism following head and neck irradiation. (1980) (80)
Misconceptions (3): calcium leaves bone only by resorption and enters only by formation. (2003) (79)
METABOLIC STUDIES IN PATIENTS WITH HYPERCALCIURIA. (1964) (79)
Osteoclast precursors as leukocytes: importance of the area code. (1998) (78)
Deficient Bone Formation in Idiopathic Juvenile Osteoporosis: A Histomorphometric Study of Cancellous Iliac Bone (2000) (77)
Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II. (1985) (77)
The skeletal effects of glucocorticoid excess override those of orchidectomy in mice. (2004) (73)
Parathyroid cell proliferation in the rat: effect of age and of phosphate administration and recovery. (1996) (72)
Bone age, mineral density, and fatigue damage (2005) (71)
Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis. (1987) (69)
What is the normal rate of bone remodeling? (2004) (68)
Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia. (1987) (66)
High Bone Turnover Is Intrinsically Harmful: Two Paths to a Similar Conclusion: The Parfitt View (2002) (65)
Misconceptions (1): epiphyseal fusion causes cessation of growth. (2002) (64)
Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes. (1971) (64)
Determination of osteocalcin in human serum: results with two kits compared with those by a well-characterized assay. (1985) (63)
Growth hormone and adult bone remodelling (1991) (61)
Interpretation of bone densitometry measurements: Disadvantages of a percentage scale and a discussion of some alternatives (1990) (58)
Differences in osteocyte and lacunar density between Black and White American women. (2006) (58)
The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. (2002) (57)
Plasma calcium control at quiescent bone surfaces: a new approach to the homeostatic function of bone lining cells. (1989) (57)
The basal rate of cell proliferation in normal human parathyroid tissue: implications for the pathogenesis of hyperparathyroidism (1997) (56)
Vitamin D receptor genotypes in osteoporosis (1994) (56)
Bone mass, skin color and body size among black and white women. (1988) (52)
For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. (2013) (52)
Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat. (1984) (51)
Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion. (1969) (51)
Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism. (1996) (51)
Use of bisphosphonates in the prevention of bone loss and fractures. (1991) (51)
CHAPTER 63 – Vitamin D and the Pathogenesis of Rickets and Osteomalacia (1997) (49)
Effects of Different Regimens of Sodium Fluoride Treatment for Osteoporosis on the Structure, Remodeling and Mineralization of Bone (1998) (48)
Gompertzian growth curves in parathyroid tumours: further evidence for the set‐point hypothesis (1997) (47)
Study of parathyroid function in man by EDTA infusion. (1969) (47)
Identification of the mineralization front: comparison of a modified toluidine blue stain with tetracycline fluorescence. (1983) (45)
Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure. (1986) (45)
The mineralization index--a new approach to the histomorphometric appraisal of osteomalacia. (2004) (44)
Principal components analysis of regional bone density in black and white women: relationship to body size and composition. (1991) (43)
Morphometry of bone resorption: introduction and overview. (1992) (41)
Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. (1982) (40)
Atypical insufficiency fractures confused with Looser zones of osteomalacia. (1987) (40)
Biologic and therapeutic determinants of bone mineral density in multiple myeloma. (1998) (38)
Skin color and body size as risk factors for osteoporosis (2005) (38)
Bone effects of space flight: analysis by quantum concept of bone remodelling. (1981) (38)
New Concepts of Bone Remodeling: A Unified Spatial and Temporal Model with Physiologic and Pathophysiologic Implications (2003) (37)
Relationship between bone formation rate and osteoblast surface on different subdivisions of the endosteal envelope in aging & osteoporosis. (1992) (37)
Weight of normal parathyroid glands in patients with parathyroid adenomas. (2005) (37)
Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. (1986) (37)
Nutritional, endocrine, and demographic aspects of osteoporosis. (1981) (36)
Relation between parathyroid cell mass and plasma calcium concentration in normal and uremic subjects. A theoretical model with an analysis of the concept of autonomy, and speculations on the mechanism of parathyroid hyperplasia. (1969) (35)
Rates of cell proliferation in adenomatous, suppressed, and normal parathyroid tissue: implications for pathogenesis. (1998) (35)
The attainment of peak bone mass: what is the relationship between muscle growth and bone growth? (2004) (34)
The spectrum of hypoparathyroidism. (1972) (34)
Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism. (1972) (34)
A new method for identification of cement lines in undecalcified, plastic embedded sections of bone. (1986) (34)
PRIMARY OSTEOPOROSIS (1980) (33)
Osteopenia and Fractures Occurring During Maintenance Hemodialysis A New Form of Renal Osteodystrophy (1972) (32)
The parathyroid glands in chronic renal failure: a study of their growth and other properties made on the basis of findings in patients with hypercalcemia. (1989) (32)
Cell kinetics in parathyroid adenomas: evidence for decline in rates of cell birth and tumour growth, assuming clonal origin (1991) (32)
Accelerated Cortical Bone Loss: Primary and Secondary Hyperparathyroidism (1986) (31)
CHAPTER 5 – Skeletal Heterogeneity and the Purposes of Bone Remodeling: Implications for the Understanding of Osteoporosis (2008) (29)
Chapter 36 – Skeletal Heterogeneity and the Purposes of Bone Remodeling: Implications for the Understanding of Osteoporosis (2013) (27)
The contribution of bone histology to understanding the pathogenesis and improving the management of osteoporosis. (1982) (27)
Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. (2009) (27)
Familial neonatal hypoproteinaemia with exudative enteropathy and intestinal lymphangiectasis. (1966) (26)
Dependence of Bone Yield (Volume of Bone Formed per Unit of Cement Surface Area) on Resorption Cavity Size During Osteonal Remodeling in Human Rib: Implications for Osteoblast Function and the Pathogenesis of Age-Related Bone Loss (2009) (26)
Investigation of disorders of the parathyroid glands. (1974) (25)
Radiation-associated hyperparathyroidism: comparison of adenoma growth rates, inferred from weight and duration of latency, with prevalence of mitosis. (1993) (25)
Bone Histomorphometry: System for Standardization of Nomenclature, Symbols, and Units (1988) (23)
Case report: Idiopathic acquired diffuse osteosclerosis in a young woman (1990) (23)
Bone histology in metabolic bone disease: the diagnostic value of bone biopsy. (1979) (23)
Independent and Combined Contributions of Cancellous and Cortical Bone Deficits to Vertebral Fracture Risk in Postmenopausal Women (2006) (23)
1,25-DIHYDROXYCHOLECALCIFEROL AND 1α-HYDROXYCHOLECALCIFEROL IN HYPOPARATHYROIDISM (1974) (22)
Life history of osteocytes: relationship to bone age, bone remodeling, and bone fragility. (2002) (21)
Letter: Correction of plasma calcium measurements. (1974) (21)
Forearm bone density in primary hyperparathyroidism: long‐term follow‐up with and without parathyroidectomy (2003) (20)
Diffuse osteosclerosis in intravenous drug abusers. (1993) (20)
Parathyroid Growth: Normal and Abnormal (2015) (20)
Hormonal Influences on Bone Remodeling and Bone Loss: Application to the Management of Primary Hyperparathyroidism (1996) (20)
Proceedings: The effect of chronic renal failure and maintenance hemodialysis on bone mineral content of the radius. (1976) (19)
Primary diffuse microscopical hyperplasia of the parathyroid glands: surgical importance. (1976) (18)
Primary hyperparathyroidism. A cause of hypercalciuria and renal stones in patients with medullary sponge kidney. (1977) (18)
Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment. (1995) (18)
Misconceptions V—Activation of osteoclasts is the first step in the bone remodeling cycle (2006) (16)
Vitamin-D treatment in hypoparathyroidism. (1970) (16)
Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid. (1991) (16)
The ambiguity of interstitial bone thickness: a new approach to the mechanism of trabecular thinning. (1991) (15)
Chest pain and fleeting neurological signs (2005) (15)
Difference in label length between demethylchlortetracycline and oxytetracycline: Implications for the interpretation of bone histomorphometric data (1991) (15)
Pharmacologic Manipulation of Bone Remodelling and Calcium Homeostasis (1990) (15)
Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25 dihydroxyvitamin D. (1980) (14)
The phosphaturic action of PTH in the steady state in patients with normal and impaired renal function. (1980) (14)
Cortical Porosity in Postmenopausal and Adolescent Wrist Fractures (1986) (14)
Bone remodeling in type I osteoporosis (1991) (14)
The acute effects of mersalyl, chlorothiazide and mannitol on the renal excretion of calcium and other ions in man. (1969) (13)
The Resemblance between Sarcoidosis with Hypercalcaemia and Hyperparathyroidism (1960) (13)
THE EFFECT OF CELLULOSE PHOSPHATE ON CALCIUM METABOLISM IN PATIENTS WITH HYPERCALCIURIA. (1964) (13)
Adult hypoparathyroidism: treatment with calcifediol. (1978) (13)
Producing frozen sections of calcified bone. (1993) (12)
Metacarpal cortical dimensions in hypoparathyroidism, primary hyperparathyroidism and chronic renal failure (1976) (12)
Bone Erosion in Rheumatoid Arthritis (1978) (12)
Urinary total hydroxyproline measured by HPLC: comparison of spot and timed urine collections. (1990) (12)
Clinical aspects of metabolic bone disease : proceedings of the International Symposium on Clinical Aspects of Metabolic Bone Disease, Henry Ford Hospital, Detroit, Mich., June 26-29, 1972 (1973) (11)
Effect of cellulose phosphate on calcium and magnesium homeostasis: studies in normal subjects and patients with latent hypoparathyroidism. (1975) (11)
Hypophosphatemic vitamin D refractory rickets and osteomalacia. (1972) (10)
Phosphate administration increases both size and number of parathyroid cells in adult rats (2006) (10)
Problems in the application of in vitro systems to the study of human bone remodeling. (1995) (10)
Comparison of aluminum related with vitamin D related osteomalacia by tetracycline based bone histomorphometry. (1986) (10)
Bone Fragility in Osteomalacia: Mechanisms and Consequences (1986) (10)
Calcium-Induced Natriuresis: Physiologic and Clinical Implications (2000) (9)
Renal function in treated hypoparathyroidism. A possible direct nephrotoxic effect of vitamin D. (1977) (9)
A unique case of adult hypophosphatemic osteomalacia. (1993) (9)
Hyperparathyroidism and medullary sponge kidney. (1977) (9)
Mean wall thickness in gallocyanine-stained sections: Comparison with ultraviolet light (UVL) and polarized light (PL) microscopy (1985) (9)
Gas-liquid chromatography of vitamin D as trimethylsilyl derivatives. (1972) (9)
Composite index of skeletal mass: Principal components analysis of regional bone mineral densities (1992) (9)
Acetazolamide and renal stone formation. (1970) (9)
CHAPTER 28 – Modeling and Remodeling: How Bone Cells Work Together (2005) (8)
CHAPTER 18 – Parathyroid Growth: Normal and Abnormal (2001) (8)
Effect of cellulose phosphate and dietary calcium restriction in primary hyperparathyroidism. (1975) (8)
Recent contributions of iliac bone histomorphometry to understanding the anabolic effect of parathyroid hormone (2002) (8)
Misconceptions IV--the hypophosphatemia of primary hyperparathyroidism is the result of renal phosphate wasting. (2004) (8)
SCREENING FOR VITAMIN D DEPLETION (1984) (8)
Hyperthyroidism and hypercalcaemia. (1970) (8)
Metabolic bone disease. (1972) (8)
THE INCIDENCE OF HYPOPARATHYROID TETANY AFTER THYROID OPERATIONS: RELATIONSHIP TO AGE, EXTENT OF RESECTION AND SURGICAL EXPERIENCE (1971) (7)
Problems in the Application of In Vitro Systems to the Study of Human Bone Remodeling (2014) (7)
CHANGES IN SERUM CALCIUM AND PHOSPHORUS DURING STILBOESTROL TREATMENT OF OSTEOPOROSIS. (1965) (7)
Parathyroid hormone and corticosteroid-induced osteoporosis (1998) (7)
CUSHING'S SYNDROME WITH "NORMAL" REPLACEMENT DOSE OF CORTISONE IN PITUITARY HYPOTHYROIDISM. (1964) (7)
Reversal of aluminum-related dialysis oseomalacia after transplantation (1985) (6)
The evolution of vitamin D-related bone disease: the importance of an early stage of increased bone turnover without impaired mineralization. (2001) (6)
Hypophosphatemia and osteoblast function in human bone disease. (1982) (6)
Screening for primary hyperparathyroidism. (1988) (5)
Richmond Smith as a clinical investigator. His work on adult periosteal bone expansion and nutritional and endocrine aspects of osteoporosis in light of current concepts. (1980) (5)
A new approach to iliac bone histomorphometry: implications for biomechanics and cell biology. (2014) (5)
Lithium and calcium metabolism. (1982) (5)
Pathogenesis and treatment of postmenopausal osteoporosis (1983) (5)
1α-Hydroxy D 3 with and without oestrogen in the treatment of osteoporosis (1981) (5)
Assessment of trabecular bone status. (1983) (5)
Renal osteodystrophy. (1972) (5)
Nephrocalcinosis in intestinal bypass patients. (1977) (5)
Bone density regression to the mean and the individual patient. (2001) (5)
Regulation or Permission? (2006) (5)
Size of Bone in the Aged: Endocortical Resorption (2002) (5)
The effect of cellulose phosphate on plasma and urinary magnesium at different levels of parathyroid function in man. (1976) (5)
Recent developments in bone physiology. (1983) (4)
Parathyroid stimulation after bleeding in man. (1992) (4)
Treatment of rickets and osteomalacia. (1972) (4)
An X-ray microtomography system for bone structure measurements (1992) (4)
Parathyroid hormone, phosphate and the kidney. (1980) (4)
Overview of fracture pathogenesis (1993) (3)
Reduced expression of the serpentine calcium receptor. (1996) (3)
Tribute to Harold M. Frost M.D. (2004) (3)
A clinical comparison of two preparations of calciferol. (1968) (3)
Hypoparathyroidism and biochemical screening. (1981) (3)
Vitamin D Receptor Status in Parathyroid Adenomasc (2001) (3)
HYPERCALCAEMIC NEPHROPATHY. (1964) (3)
Serum markers of bone formation in parenteral nutrition patients (1991) (3)
Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women. (1995) (3)
Removal of cholesterol from serum extracts of vitamin D by thin-layer chromatography. (1972) (3)
The localization of aluminum in bone: implications for the mechanism of fixation and for the pathogenesis of aluminum-related bone disease. (1988) (3)
Comparison of Methods for Staining Mast Cells in Undecalcified Sections of Bone (1990) (3)
Paget’s disease of bone and hyperparathyroidism: Coincidence or causal relationship? (1979) (3)
Large calcium fluxes that are not related to remodeling exist. (2003) (3)
Bone histomorphometry: The only window on the BMU, the only tool of in vivo bone cell biology (1996) (3)
THE SEMANTICS OF STEATORRHOEA. (1965) (2)
Testing for hypoparathyroidism. (1967) (2)
Parathyroid stimulation after bleeding in man (1992) (2)
Glucocorticoid Osteoporosis - Relations to BMU Theory and to Bone Cell Birth (2001) (2)
Risk of vertebral fracture after lung transplantation in cystic fibrosis. (1997) (2)
Parathyroid hormone resistance in renal allograft recipients. (1982) (2)
Effect of melengestrol acetate on bone dynamics of monkey ribs (1976) (2)
Effects of strontium ranelate – results important but presentation muddled (2008) (2)
Vitamin D "resistance" and bioavailability of calciferol tablets. (1977) (2)
Nuclear Profile Area of Osteoblasts in Normal, Osteoporotic, and Fluoride-Treated Subjects (1996) (2)
Treatment of osteoporosis: theoretical possibilities. (1982) (2)
Osteomalacia and Phenytoin Therapy (1995) (2)
Response to letter 'Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities'. (1994) (1)
47 Nephrogenous cyclic AMP (Nc'AMP): An alternative to parathyroid hormone (PTH) immunoassay (1979) (1)
Hypocalcaemia after thyroidectomy. (1976) (1)
Skeletal heterogeneity and the purposes of bone remodeling (2021) (1)
Randomized trial of parathyroidectomy in mild, asymptomatic primary hyperparathyroidism as measured by the SF‐36 health survey (2000) (1)
H.-I. Chu: Pioneer clinical investigator of vitamin D deficiency and osteomalacia in China. A scientific and personal tribute (1985) (1)
Comment on "true" and "apparent" bone density measurement in children with GH deficiency. (1999) (1)
Vitamin D receptor genotypes in osteoporosis. (1994) (1)
MALNUTRITION IN ELDERLY PEOPLE. AUTHORS' REPLY (1997) (1)
Delayed recognition of postoperative hypoparathyroidism. (1967) (1)
Hypophosphatemic Osteomalacia and Adult Fanconi Syndrome Due to Light-Chain Nephropathy. Another Form of Oncogenous Osteomalacia (1987) (1)
Idiopathic osteoporosis: Is the osteoblast to blame? [4] (multiple letters) (1998) (1)
HYPERCALCÆMIC NEPHROPATHY (1964) (1)
Irreversibility of advanced osteoporosis: Limited role for pharmacologic intervention (1994) (1)
Stem cells in bone formation growth and remodeling (2002) (1)
Malnutrition in the elderly people. (1997) (1)
Letter: 1,25-Dihydroxycholecalciferol and 1 alpha-hydroxycholecalciferol in hypoparathyroidism. (1974) (0)
THE SEMANTICS OF STEATORRHŒA (1965) (0)
Compact bone and fracture risk. (1992) (0)
Calcium Balances and Calcium Metabolism (1960) (0)
Bone age, mineral density, and fatigue damage. Discussion (1993) (0)
Hypophosphatemic osteomalacia (HO) (1990) (0)
H.I. CHU: pioneer clinical investigator of vitamin D deficiency and osteomalacia in China. A scientific and personal tribute. (1986) (0)
Familial Neonatal Hypoproteinaemia TABLE I Results of Protein Determinations in Normal Members of the Family Father Mother (2007) (0)
Three-Year Follow-up on the Effects of Transdermal Estrogen (1997) (0)
Conclusion: Research prospects and initiatives (1993) (0)
Poster abstracts from the 34 th Meeting of the International Sun Valley Workshop on Skeletal Tissue Biology 1-4 August 2004 , Sun Valley , Idaho , USA Program Chairman : (2004) (0)
Harold Frost–a personal note (2004) (0)
Use of Calciferol and its Metabolites and Analogues in Osteoporosis (1988) (0)
Refractory Hypercalcemia in Sarcoidosis: Exacerbation by thiazide diuretics, differentiation from primary hyperparathyroidism, and possible role of prolactin (2019) (0)
HYPOCALCÆMIA AFTER THYROIDECTOMY (1976) (0)
Thyrocalcitonin (1967) (0)
Hyperparathyroidism — primary, secondary, and tertiary (2000) (0)
Cardioprotective effect of estrogen. (1992) (0)
Nuclear profile area of osteoblasts in normal, osteoporotic, and fluoride treated subjects (1992) (0)
Comment on calcium-regulated renal calcium handling in healthy men. (1999) (0)
Reply to letter by Holmes and Kummerow (1983) (0)
Bone histomorphometry: standardization of nomenclature, symbols and units. Summary of proposed system. (1988) (0)
Differential excretion of divalent cations in hypertensive subjects. (1968) (0)
Plasma calcium homeostasis. (2004) (0)
Comment on Therapeutic controversy: Thyroid surgery--the choice. (1998) (0)
Prevention of Hypercalcemia (Ca ↑) in Vitamin (D) Therapy of Hypoparathyroidism (HoPT). (1969) (0)
Bone fragility and bone architecture: Macroscopic, microscopic and ultramicroscopic aspects (1990) (0)
Letter to the Editor (1990) (0)
Bone Erosion in Rheumatoid Arthritist (2019) (0)
Vitamin D receptor status in parathyroid adenomas. (2001) (0)
Fragile bones in fragile people: age related fractures (1991) (0)
"A.T. 10" and dihydrotachysterol. (1967) (0)
Calcitriol for postmenopausal osteoporosis. (1990) (0)
NOF Task Force on bone mass measurement. (1990) (0)
Reply (1992) (0)
Idiopathic osteoporosis: is the osteoblast to blame? (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With A. Michael Parfitt?

A. Michael Parfitt is affiliated with the following schools:

A. Michael Parfitt's Academic­Influence.com Rankings

Why Is A. Michael Parfitt Influential?

A. Michael Parfitt's Published Works

Published Works

What Schools Are Affiliated With A. Michael Parfitt?

A. Michael Parfitt's AcademicInfluence.com Rankings